Ventus Therapeutics

Develops small‑molecule therapeutics for autoimmune and auto‑inflammatory diseases treatment

placeBoston, Massachusetts, United States calendar_todayFounded 2019 groups76 employees language ventustx.com

Registered entities

Innovation

25 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 6,132 times.

YearFilings
20222
20238
202414
202521
20266

Social engagement

Social engagement: 16.9K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

12 investors on record; lead investors include Versant Ventures, RA Capital Management, Ventus, SoftBank Vision Fund.

Investor typeCountShare
Venture capital542%
Private equity217%
Other / undisclosed542%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

19 Jan 2025 · Senior Manager, Clinical Supply Chain Management · null

Based on job postings tracked across public sources.

Recent activity

17 Apr 2026
Event
conference
20 Jan 2026
Event
Keystone Symposia on Molecular & Cellular Biology on Autoimmunity & Autoinflammation: Translating Basic Mechanisms into Novel Therapeutic Approaches
7 Jan 2026
Product launch
Coming soon